In the first immunohistochemical study of a large panel of epithelial ovarian cancers and other gynecological cancers, AMHR2 was detected in nearly 70% of epithelial ovarian cancers,13 as well as in most endometrial cancers and ovarian dysgerminomas.13, 34. Here, AMHR2 is linked to female reproductive organ cancer.